Publications (58) Publications in which a researcher has participated


  1. 3-Oxopyridazin-5-yl-Chalcone Hybrids: Potent Antiplatelet Agents That Prevent Glycoprotein IIb/IIIa Activation

    ChemistrySelect, Vol. 2, Núm. 17, pp. 4920-4933

  2. A Positive Allosteric Modulator of the Serotonin 5-HT2C Receptor for Obesity

    Journal of Medicinal Chemistry, Vol. 60, Núm. 23, pp. 9575-9584

  3. Adherence and safety study in patients on treatment with capecitabine

    Farmacia Hospitalaria, Vol. 41, Núm. 2, pp. 204-221

  4. Advances on the formulation of proteins using nanotechnologies

    Journal of Drug Delivery Science and Technology, Vol. 42, pp. 155-180

  5. Biodistribution of radiolabeled polyglutamic acid and PEG-polyglutamic acid nanocapsules

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 112, pp. 155-163

  6. Burden assessment in caregivers of patients with home artificial nutrition: A need and a challenge

    European Journal of Clinical Nutrition, Vol. 71, Núm. 2, pp. 192-197

  7. Chitosan-coated mesoporous MIL-100(Fe) nanoparticles as improved bio-compatible oral nanocarriers

    Scientific Reports, Vol. 7

  8. Cis-Platinum Complex Encapsulated in Self-Assembling Cyclic Peptide Dimers

    Organic Letters, Vol. 19, Núm. 10, pp. 2560-2563

  9. Clinical Experience with the Integrase Inhibitors Dolutegravir and Elvitegravir in HIV-infected Patients: Efficacy, Safety and Tolerance

    Basic and Clinical Pharmacology and Toxicology, Vol. 121, Núm. 5, pp. 442-446

  10. Clinical profile and outcomes in octogenarians with atrial fibrillation: A community-based study in a specific European health care area

    International Journal of Cardiology, Vol. 243, pp. 211-215

  11. Computer-aided design of multi-target ligands at A1R, A2AR and PDE10A, key proteins in neurodegenerative diseases

    Journal of Cheminformatics, Vol. 9, Núm. 1

  12. Contralateral choroiditis secondary to combination therapy with simeprevir, sofosbuvir and ribavirin

    European Journal of Clinical Pharmacy, Vol. 19, Núm. 4, pp. 291-293

  13. Cysteamine ophthalmic hydrogel for the treatment of ocular cystinosis

    Farmacia Hospitalaria, Vol. 41, Núm. 6, pp. 678-687

  14. Cysteamine polysaccharide hydrogels: Study of extended ocular delivery and biopermanence time by PET imaging

    International Journal of Pharmaceutics, Vol. 528, Núm. 1-2, pp. 714-722

  15. Development of Fluorescent Probes that Target Serotonin 5-HT2B Receptors

    Scientific Reports, Vol. 7, Núm. 1

  16. Diabetes-induced hepatic oxidative stress: a new pathogenic role for glycated albumin

    Free Radical Biology and Medicine, Vol. 102, pp. 133-148

  17. Effect of Nitrogen Atom Substitution in A3 Adenosine Receptor Binding: N-(4,6-Diarylpyridin-2-yl)acetamides as Potent and Selective Antagonists

    Journal of Medicinal Chemistry, Vol. 60, Núm. 17, pp. 7502-7511

  18. Effect of tyrosine kinase inhibitors on the glucose levels in diabetic and nondiabetic patients

    Indian Journal of Cancer, Vol. 54, Núm. 1, pp. 136-143

  19. El impacto de la nanotecnología en el desarrollo de nuevos medicamentos

    Revista Real Academia Galega de Ciencias, Núm. 36, pp. 27-28

  20. Enantiospecific Recognition at the A2B Adenosine Receptor by Alkyl 2-Cyanoimino-4-substituted-6-methyl-1,2,3,4-tetrahydropyrimidine-5-carboxylates

    Journal of Medicinal Chemistry, Vol. 60, Núm. 8, pp. 3372-3382